News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
860,759 Results
Type
Article (87423)
Company Profile (760)
Press Release (772554)
Multimedia
Podcasts (172)
Webinars (28)
Section
Business (233052)
Career Advice (4139)
Deals (39795)
Drug Delivery (136)
Drug Development (91247)
Employer Resources (203)
FDA (18280)
Job Trends (17399)
News (397382)
Policy (39926)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (124)
Alliances (56979)
ALS (145)
Alzheimer's disease (1680)
Antibody-drug conjugate (ADC) (241)
Approvals (18297)
Artificial intelligence (487)
Autoimmune disease (73)
Automation (25)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (159)
Biotechnology (484)
Bladder cancer (127)
Brain cancer (52)
Breast cancer (498)
Cancer (3914)
Cardiovascular disease (338)
Career advice (3556)
Career pathing (38)
CAR-T (246)
CDC (57)
Cell therapy (682)
Cervical cancer (33)
Clinical research (75444)
Collaboration (1378)
Company closure (4)
Compensation (938)
Complete response letters (59)
COVID-19 (2956)
CRISPR (81)
C-suite (585)
Cystic fibrosis (134)
Data (4405)
Decentralized trials (2)
Denatured (61)
Depression (110)
Diabetes (452)
Diagnostics (7091)
Digital health (36)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (230)
Drug pricing (190)
Drug shortages (36)
Duchenne muscular dystrophy (203)
Earnings (98792)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (132939)
Executive appointments (987)
FDA (20724)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (14)
Funding (1250)
Gene editing (173)
Generative AI (48)
Gene therapy (545)
GLP-1 (1019)
Government (5384)
Grass and pollen (7)
Guidances (340)
Healthcare (20937)
HIV (48)
Huntington's disease (37)
IgA nephropathy (57)
Immunology and inflammation (240)
Immuno-oncology (20)
Indications (53)
Infectious disease (3192)
Inflammatory bowel disease (186)
Inflation Reduction Act (15)
Influenza (96)
Intellectual property (187)
Interviews (815)
IPO (17926)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (15)
Labor market (77)
Layoffs (640)
Leadership (33)
Legal (10148)
Liver cancer (91)
Longevity (12)
Lung cancer (559)
Lymphoma (265)
Machine learning (30)
Management (66)
Manufacturing (635)
MASH (138)
Medical device (14869)
Medtech (14892)
Mergers & acquisitions (22740)
Metabolic disorders (1151)
Multiple sclerosis (137)
NASH (23)
Neurodegenerative disease (227)
Neuropsychiatric disorders (60)
Neuroscience (2710)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (57)
Obesity (556)
Opinion (312)
Ovarian cancer (133)
Pain (165)
Pancreatic cancer (170)
Parkinson's disease (242)
Partnered (30)
Patents (416)
Patient recruitment (309)
Peanut (57)
People (66248)
Pharmaceutical (144)
Pharmacy benefit managers (27)
Phase I (23271)
Phase II (32746)
Phase III (24666)
Pipeline (2704)
Policy (295)
Postmarket research (3554)
Preclinical (10495)
Press Release (72)
Prostate cancer (200)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (666)
Real estate (7421)
Recruiting (78)
Regulatory (27987)
Reports (65)
Research institute (2688)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (70)
Schizophrenia (134)
Series A (207)
Series B (156)
Service/supplier (30)
Sickle cell disease (79)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4318)
State (2)
Stomach cancer (17)
Supply chain (100)
Tariffs (95)
The Weekly (109)
Vaccines (1040)
Venture capital (66)
Weight loss (395)
Women's health (58)
Worklife (21)
Date
Today (84)
Last 7 days (642)
Last 30 days (2350)
Last 365 days (33437)
2025 (26295)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1279)
Alabama (80)
Alaska (7)
Arizona (302)
Arkansas (14)
Asia (50966)
Australia (8956)
California (9410)
Canada (2853)
China (894)
Colorado (400)
Connecticut (420)
Delaware (267)
Europe (117076)
Florida (1388)
Georgia (315)
Hawaii (3)
Idaho (67)
Illinois (810)
India (51)
Indiana (459)
Iowa (19)
Japan (322)
Kansas (124)
Kentucky (38)
Louisiana (20)
Maine (77)
Maryland (1275)
Massachusetts (7093)
Michigan (313)
Minnesota (563)
Mississippi (4)
Missouri (119)
Montana (33)
Nebraska (26)
Nevada (107)
New Hampshire (77)
New Jersey (2616)
New Mexico (32)
New York (2568)
North Carolina (1409)
North Dakota (10)
Northern California (4247)
Ohio (295)
Oklahoma (22)
Oregon (50)
Pennsylvania (1961)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (49)
South Dakota (1)
Southern California (3598)
Tennessee (149)
Texas (1475)
United States (34847)
Utah (282)
Virginia (248)
Washington D.C. (83)
Washington State (815)
West Virginia (4)
Wisconsin (97)
Wyoming (1)
There are 860,759 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT
October 20, 2025
·
9 min read
Press Releases
Parabilis Medicines Presents Clinical Data Demonstrating First-Ever Drugging of Key Cancer Driver with FOG-001
October 20, 2025
·
8 min read
Press Releases
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
October 20, 2025
·
13 min read
Press Releases
4DMT Announces New Employment Inducement Grants - October 17, 2025
October 20, 2025
·
2 min read
Press Releases
Jade Biosciences Announces New Data Presentations for JADE101 at the American Society of Nephrology Kidney Week 2025
October 20, 2025
·
6 min read
Press Releases
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - October 17, 2025
October 20, 2025
·
4 min read
Press Releases
FDA APPROVES TEZSPIRE® FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
October 20, 2025
·
21 min read
Press Releases
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - October 17, 2025
October 20, 2025
·
3 min read
Press Releases
FDA approves Novo Nordisk’s oral semaglutide for cardiovascular (CV) risk reduction in adults with type 2 diabetes who are at high risk, including those who have not had a prior CV event
October 20, 2025
·
12 min read
Press Releases
Citius Pharmaceuticals and Citius Oncology to Participate in Upcoming October 2025 Conferences
October 20, 2025
·
2 min read
1 of 86,076
Next
